Aurinia Pharmaceuticals (AUPH) Change in Intangibles (2020 - 2024)
Aurinia Pharmaceuticals (AUPH) reported Change in Intangibles of $129000.0 for Q3 2024, up 360.71% on a YoY basis from $28000.0 in Q4 2023, and up 53.57% quarter-over-quarter from $84000.0 in Q2 2024.
Aurinia Pharmaceuticals (AUPH) Change in Intangibles (2020 - 2024) Analysis & Trends
Aurinia Pharmaceuticals has reported Change in Intangibles for 4 years, with the latest figure at $129000.0 in Q3 2024.
- For the quarter ending Q3 2024, Change in Intangibles rose 360.71% year-over-year to $129000.0; the trailing twelve-month figure through Sep 2024 stood at $253000.0 (up 5.42% YoY), and the FY2019 full-year result was $16000.0, changed N/A from the prior year.
- Change in Intangibles for Q3 2024 stood at $129000.0, up from $84000.0 in the prior quarter.
- The five-year high for Change in Intangibles was $162000.0 in Q1 2023, with the low at -$83000.0 in Q4 2020.
- Historically, Change in Intangibles has averaged $38750.0 across 4 years, with a median of $29500.0 in 2020.
- The largest YoY upside for Change in Intangibles was 360.71% in 2024 against a maximum downside of 92.59% in 2024.
- Aurinia Pharmaceuticals' Change in Intangibles stood at -$83000.0 in 2020, then soared by 92.77% to -$6000.0 in 2021, then surged by 566.67% to $28000.0 in 2023, then surged by 360.71% to $129000.0 in 2024.
- The last three Change in Intangibles figures came in at $129000.0 (Q3 2024), $84000.0 (Q2 2024), and $12000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aurinia Pharmaceuticals | 2.18 Bn | 1.80 Bn | 71.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 129,000.00 |
| Sep 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 84,000.00 |
| Jun 30, 2024 | 84,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Sep 30, 2023 | 28,000.00 |
| Sep 30, 2023 | 28,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Dec 31, 2020 | -83,000.00 |
| Dec 31, 2020 | -83,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Sep 30, 2020 | 4,000.00 |